WASHINGTON D.C. 20549 | OMB Number |
                                                                 | 3235-0058   |
                                  FORM 12b-25                    |  expires    |
                           NOTIFICATION OF LATE FILING           | 01/31/2002  |
                                                                 |             |
                                                                 | SEC File #  |
                                                                 |  000-       |
                                                                 |   CUSIP #   |
                                                                 |             |
check box
     Form 10-K [ ]  Form 20-F [ ] Form 11-K [ ]  Form 10-Q [x]  Form N-SAR [ ]
     Form N-CSR [ ]

                       For Period Ended: November 30, 2009
                       [ ] Transition Report on Form 10-K
                       [ ] Transition Report on Form 20-F
                       [ ] Transition Report on Form 11-K
                       [ ] Transition Report on Form 10-Q
                       [ ] Transition Report on Form N-SAR
                    For the Transition Period Ended: ________________________

|                                                                           |
|Read Instruction (on back page) Before Preparing Form, Please Print or Type|
|                                                                           |
| Nothing in this form shall be construed to imply that the Commission has  |
|              verified any information contained herein.                   |

     If the notification relates to a portion of the filing checked above,
              identify the Item(s) to which the notification relates:

Full Name of Registrant:
     Biomerica, Inc.
Former Name if Applicable

Address of Principal Executive Office (Street and Number)
     17571 Von Karman Avenue
City, State, Zip Code
     Irvine, CA 92614

PART II - RULES 12b-25 (b) AND (c)

If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)

        |  (a)    The reasons described in reasonable detail in Part III of this
        |         form could not be eliminated without unreasonable effort or
        |         expense;
        |  (b)    The subject annual report, semi-annual report, transition
 XX     |         report on Form 10-K, Form 20-F, 11-K, Form N-SAR or Form
 --     |         N-CSR, or portion thereof, will be filed on or before the
        |         fifteenth calendar day following the prescribed due date; or
        |         the subject quarterly report or transition report on Form 10-Q
        |         or subject distribution report on Form 10-D, or portion
        |         thereof will be filed on or before the fifth calendar day
        |         following the prescribed due date; and
        |  (c)    The accountant's statement or other exhibit required by Rule
        |         12b-25(c) has been attached if applicable.


State below in reasonable detail the reasons why Forms 10-K, 20-F, 11-K, 10-Q,
N-SAR, N-CSR or the transition report or portion thereof could not be filed
within the prescribed time period.

The Registrant is currently gathering and analyzing certain accounting
information and undergoing its periodic quarterly review by its auditors in
order to complete its Form 10-Q. The process was delayed in part by the move of
the Company's facilities to its new location. The data and review could not be
completed earlier without unreasonable effort and expense.


(1) Name and telephone number of person to contact in regard to this

        Janet Moore                  949               645-2111
----------------------------   -----------------   ---------------
          (Name)                  (Area Code)       (Telephone No.)

(2) have all other periodic reports required under section 13 or 15(d) of the
Securities Exchange Act of 1934 or section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).

                                                        [x]Yes  [ ]No

(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?

                                                        [ ]Yes  [x]No

If so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.


                                   Biomerica, Inc.
                  (Name of Registrant as Specified in Charter)

has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.

Date: January 15, 2010                  By: /s/ Zackary S. Irani
      ----------------                      ---------------------------------
                                            Zackary S. Irani,
                                            Chief Executive Officer

INSTRUCTION; The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.

Intentional misstatements or omissions of fact constitute Federal Criminal
                        Violations (See 18 U.S.C. 1001).

                              GENERAL INSTRUCTIONS

1.  This form is required by Rule 12b-25 (17 CRF 240.12b-25) of the General
    Rules and Regulations under the Securities Exchange Act of 1934.

2.  One signed original and four conformed copies of this form and amendments
    thereto must be completed and filed with the Securities and Exchange
    Commission, Washington, D.C. 20549, in accordance with Rule 0-3 of the
    General Rules and Regulations under the Act. The information contained in or
    filed with the form will be made a matter of public record in the Commission

3.  A manually signed copy of the form and amendments thereto shall be filed
    with each national securities exchange on which any class of securities of
    the registrant is registered.

4.  Amendments to the notifications must also be filed on form 12b-25 but need
    not restate information that has been correctly furnished. The form shall be
    clearly identified as an amended notification.

5.  ELECTRONIC FILERS. This form shall not be used by electronic filers unable
    to timely file a report solely due to electronic difficulties. Filers unable
    to submit a report within the time period prescribed due to difficulties in
    electronic filing should comply with either Rule 201 or Rule 202 of
    Regulation S-T (Section 232.201 or Section 232.202 of this chapter) or apply
    for an adjustment in filing date pursuant to Rule 13(b) of Regulation S-T
    (Section 232.13(b) of this chapter).